07.14.2016
Clinical Alerts
06.29.2016
Docusate Sodium Liquid Formulations Alert
The Centers for Disease Control and Prevention (CDC), in collaboration with the Food and Drug Administration (FDA), has issued an alert regarding a multi-state outbreak...
06.15.2016
Proton Pump Inhibitors (PPIs) and Steroid Use
In a recent JAMA Intern Med article, a patient case describing an allergic reaction to a PPI is presented. The article reiterates that PPIs are...
06.15.2016
The Death Rattle Dilemma
Terminal secretions, also known as “death rattle”, is a type of noisy breathing from retained secretions that sounds like snoring or rattling during the inspiratory...
05.11.2016
Cystic Fibrosis: New therapies developed
Cystic fibrosis is a life-limiting genetic disorder that affects several body systems including the lung (bronchiectasis), pancreas (malabsorption), liver (biliary cirrhosis), and sweat glands (heat...
05.11.2016
Opioids/Chronic Substance Abuse Disorder
The Center to Advance Palliative Care (CAPC) is a national organization dedicated to increasing the availability of quality palliative services for people facing serious illness....
04.12.2016
Association of Proton Pump Inhibitors with Risk of Dementia
Proton pump inhibitors (PPIs) are widely used for the treatment of gastrointestinal diseases but have also been associated with cognitive decline. Gomm and colleagues performed...
04.12.2016
Antipsychotics and Mortality Risk in Parkinson’s Disease
Of patients with Parkinson’s disease (PD), 60% experience psychosis and 80% develop dementia. The use of antipsychotics to manage symptoms in this population is common. ...
03.07.2016
Management of Diabetes in Long-term Care and Skilled Nursing Facilities
The American Diabetes Association (ADA) recently published a position statement on the management of diabetes at end of life and in those receiving palliative and...